Financial Support: Endo Pharmaceuticals Inc. (Chadds Ford, PA, USA) provided funding for the study and for medical writing and editorial support by Complete Healthcare Communications, Inc. (Chadds Ford, PA, USA).
Characteristics of Menstrual vs Nonmenstrual Migraine: A Post Hoc, Within-Woman Analysis of the Usual-Care Phase of a Nonrandomized Menstrual Migraine Clinical Trial
Article first published online: 2 MAR 2010
© 2010 the Authors. Journal compilation © 2010 American Headache Society
Headache: The Journal of Head and Face Pain
Volume 50, Issue 4, pages 528–538, April 2010
How to Cite
MacGregor, E. A., Victor, T. W., Hu, X., Xiang, Q., Puenpatom, R. A., Chen, W. and Campbell, J. C. (2010), Characteristics of Menstrual vs Nonmenstrual Migraine: A Post Hoc, Within-Woman Analysis of the Usual-Care Phase of a Nonrandomized Menstrual Migraine Clinical Trial. Headache: The Journal of Head and Face Pain, 50: 528–538. doi: 10.1111/j.1526-4610.2010.01625.x
Guarantor: Xiaojun Hu, PhD.
Role of the Funding Source: Endo Pharmaceuticals Inc. designed the study, collected and analyzed the data, performed initial data interpretation, and decided to collaborate with an external researcher with expertise in this area for further data interpretation. Based on the collaborative efforts by Endo Pharmaceuticals Inc. and the external author, the decision was made to seek publication; all authors participated in manuscript development, suggested further data analyses to enhance the manuscript, and participated in submission of the final manuscript.
Details of Contributors: All authors declare we had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors contributed to the writing of the manuscript.
Conflict of Interest: With the exception of Dr. E.A.M., all authors were employees of the study sponsor, Endo Pharmaceuticals Inc., at the time the study was performed. Dr. E.A.M. is an independent clinician and researcher who specializes in headache research and currently works at The City of London Migraine Clinic. She has received honoraria as an independent consultant to Addex, AstraZeneca, BTG International Ltd, Endo Pharmaceuticals, Menarini, Merck, and Pozen.
- Issue published online: 13 APR 2010
- Article first published online: 2 MAR 2010
- Accepted for publication December 11, 2009.
This article has been cited by:
- 1Burden of migraine related to menses: results from the AMPP study, The Journal of Headache and Pain, 2015, 16, 1, , , , , , ,
- 4Treatment of menstrual migraine: utility of control of related mood disturbances, Expert Review of Neurotherapeutics, 2014, 14, 5, 493, , , , , , ,
- 5Pharmacological Acute Migraine Treatment Strategies: Choosing the Right Drug for a Specific Patient, The Canadian Journal of Neurological Sciences, 2013, 40, S3, s33, , , , , , , , ,
- 6Classification of Perimenstrual Headache: Clinical Relevance, Current Pain and Headache Reports, 2012, 16, 5, 452,
- 8Menstrual Migraine: Update on Pathophysiology and Approach to Therapy and Management, Current Treatment Options in Neurology, 2012, 14, 1, 1,
- 9Migraine in women: the role of hormones and their impact on vascular diseases, The Journal of Headache and Pain, 2012, 13, 3, 177, , , ,
- 10Almotriptan for menstrually related migraine, Expert Opinion on Pharmacotherapy, 2011, 12, 12, 1933, , , ,
- 11Are Menstrual and Nonmenstrual Migraine Attacks Different?, Current Pain and Headache Reports, 2011, 15, 5, 339, ,
- 12Evaluation of the use of sumatriptan–naproxen sodium for menstrual migraine and dysmenorrhea, Expert Review of Neurotherapeutics, 2011, 11, 10, 1383, , , ,
- 14Prophylaxis and Treatment of Menstrual Migraine, Pain Management Nursing, 2011, 12, 1, S11,
- 15Migraña y Otras Cefaleas, 2011,,
- 16Genetics of Menstrual Migraine: The Epidemiological Evidence, Current Pain and Headache Reports, 2010, 14, 5, 385,
- 17Prevention and Treatment of Menstrual Migraine, Drugs, 2010, 70, 14, 1799,